Quote | Super Quote
Super Quote   |   Detail Quote   |   Interactive Chart   |   Transaction   |   Related News   |   Related Securities   |   Company Information   |   Dividend Records   |   Short Sell
00460 SIHUAN PHARM
RTNominal down0.530 -0.010 (-1.852%)
Others

27/03/2018 11:18

Sihuan Pharm year net down 15% to Rmb1.45bn; div Rmb1.3 cts

[ET Net News Agency, 27 March 2018] Sihuan Pharmaceutical (00460) said its profit
attributable to owners for the year ended 31 December 2017 dropped 15.2% year-on-year to
Rmb1,449 million.
Basic and diluted earnings per share were Rmb15.3 cents.
Revenue amounted to Rmb2,746 million, a decrease of 13.8% from a year earlier.
Gross profit margin increased from 68.7% for 2016 to 72.4% for 2017, which was mainly
due to streamlined production processes and effective cost control measures resulted from
systematic management in the Group's production units.
The proposed final dividend is Rmb1.3 cents (2016: Rmb3.8 cents with special dividend of
Rmb5.5 cents) per share, payable on or around 20 June. (HL)

Back to Others

Remark: Real time quote last updated: 23/09/2024 17:59
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2024 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.